Skip to content

comparison of two supraglottic airway devices

A comparative analysis of the Baska mask vs.I-gel for general anesthesia in surgical patient undergoing laparoscopic cholecystectomy.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/05/008671
Enrollment
80
Registered
2017-05-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- symptomatic patients of cholecystitis undergoing laparoscopic cholecystectomy

Interventions

Intervention1: I GEL vs Baska Mask: The airway will be secured with with either I gel or Baska mask as device for airway management at the time of induction of anaesthesia Control Intervention1: com

Sponsors

Dr RPGMCTanda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. American Society of Anesthesiologists physical status score I or II 2. 20 -70 yr old patient of either sex 3. Surgery time of less than 2 hr 4. An elective laparoscopic cholecystectomy

Exclusion criteria

Exclusion criteria: 1. A known or predicted difficult airway 2. A mouth opening of 3. Increased risk of aspiration of gastric contents 4. Any pathology of neck or upper respiratory tract 5. Obesity (body mass index > 30 Kg/ m2)

Design outcomes

Secondary

MeasureTime frame
Ease of removal and post operative airway morbidity in form of sore throat, dysphonia, dysphagiaTimepoint: At the time of extubation at end of surgery and at 1 hour and two hours of removal of airway device.

Primary

MeasureTime frame
Success and ease of insertion, insertion time and air leak test of baska mask vs IgelTimepoint: At the time point of securing airway and for next 5 minutes after securing airway, air leak pressures and leak fraction every 30min.till the end of surgery

Countries

India

Contacts

Public ContactDr Usha Kumari Chaudhary

Dr. Rajendra Prasad Govt. Medical College, Tanda

chaudhary.ushaarvind@gmail.com9459301813

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026